Harbor Capital Advisors Inc. Has $114,000 Holdings in Enfusion, Inc. (NYSE:ENFN)

Harbor Capital Advisors Inc. increased its stake in shares of Enfusion, Inc. (NYSE:ENFN) by 30.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,201 shares of the company’s stock after purchasing an additional 2,366 shares during the period. Harbor Capital Advisors Inc.’s holdings in Enfusion were worth $114,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Rhumbline Advisers grew its stake in shares of Enfusion by 6.2% during the first quarter. Rhumbline Advisers now owns 66,335 shares of the company’s stock worth $740,000 after purchasing an additional 3,871 shares during the period. GAMMA Investing LLC grew its stake in Enfusion by 1,098.5% in the first quarter. GAMMA Investing LLC now owns 12,165 shares of the company’s stock valued at $136,000 after acquiring an additional 11,150 shares during the period. Wellington Management Group LLP grew its stake in Enfusion by 6.1% in the fourth quarter. Wellington Management Group LLP now owns 1,035,996 shares of the company’s stock valued at $10,671,000 after acquiring an additional 59,700 shares during the period. Mackenzie Financial Corp grew its stake in Enfusion by 4.8% in the fourth quarter. Mackenzie Financial Corp now owns 31,271 shares of the company’s stock valued at $322,000 after acquiring an additional 1,434 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Enfusion by 43.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 33,721 shares of the company’s stock valued at $347,000 after acquiring an additional 10,173 shares during the period. 81.05% of the stock is owned by institutional investors and hedge funds.

Enfusion Trading Up 0.5%

NYSE:ENFN opened at $10.85 on Monday. Enfusion, Inc. has a 1 year low of $7.83 and a 1 year high of $11.80. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of 271.29, a PEG ratio of 1.85 and a beta of 0.92. The stock has a 50-day moving average price of $10.84 and a two-hundred day moving average price of $10.86.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.